Insider Trading & Ownership of ELI LILLY & Co

Location: Indianapolis, IN
Summary: The estimated value of insider holdings of ELI LILLY & Co is at least $135,446,834 dollars as of 15 Jan 2026. ELI LILLY & Co is the 10%+ Owner of Aktis Oncology, Inc. and owns shares of Aktis Oncology, Inc. (AKTS) stock worth about $135.45M.
Signature: /s/ Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
All Insider Reports: All Insider Reports

Notify me when ELI LILLY & Co files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of ELI LILLY & Co

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
AKTS	Aktis Oncology, Inc.	10%+ Owner	$135,446,834			12 Jan 2026
SGTX	Sigilon Therapeutics, Inc.	10%+ Owner				11 Aug 2023

Insider Transactions Reported by ELI LILLY & Co:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.